Discontinuation report STATEX-SUPPOSITORIES 10MG
| Report ID | 134294 |
| Drug Identification Number | 00632201 |
| Brand name | STATEX-SUPPOSITORIES 10MG |
| Common or Proper name | MORPHINE SULFATE |
| Company Name | PALADIN PHARMA INC. |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | MORPHINE SULFATE |
| Strength(s) | 10MG |
| Dosage form(s) | SUPPOSITORY |
| Route of administration | RECTAL RECTAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 10 Suppositories |
| ATC code | N02AA |
| ATC description | OPIOIDS |
| Reason for discontinuation | Manufacturing issues |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2021-01-07 |
| Remaining supply date | 2021-01-07 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 100 BLVD ALEXIS-NIHON, SUITE 600 MONTREAL, QUEBEC CANADA H4M 2P2 |
| Company contact information | 1-866-340-1112 [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2021-02-17 | French | Compare |
| v1 | 2021-02-17 | English | Compare |
Showing 1 to 2 of 2